Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life

scientific article published in June 2000

Bronchiolitis obliterans syndrome after lung transplantation and health-related quality of life is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1164/AJRCCM.161.6.9909092
P698PubMed publication ID10852770

P2093author name stringKoëter GH
Postma DS
Geertsma A
de BOER WJ
ten VERGERT EM
van Den BERG JW
van Der BIJ W
P2860cites workThe Nottingham Health Profile as a measure of quality of life following combined heart and lung transplantationQ33686868
Self-rating depression scale in an outpatient clinic. Further validation of the SDS.Q34052097
Effect of diagnosis on survival benefit of lung transplantation for end-stage lung diseaseQ34065791
Predictors of quality of life and adjustment after lung transplantationQ38472520
Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantationQ45039146
Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.Q45973174
Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation--early risk factors.Q51035800
Long-term health status and quality of life outcomes of lung transplant recipients.Q53635222
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectbronchiolitisQ424227
bronchiolitis obliteransQ614750
lung transplantQ1637912
quality of lifeQ13100823
P304page(s)1937-1941
P577publication date2000-06-01
P1433published inAmerican Journal of Respiratory and Critical Care MedicineQ4744267
P1476titleBronchiolitis obliterans syndrome after lung transplantation and health-related quality of life
P478volume161

Reverse relations

cites work (P2860)
Q36755805A thematic analysis of quality of life in lung transplant: the existing evidence and implications for future directions
Q36093259Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies
Q37867763Chronic allograft dysfunction
Q36773665Depression after lung transplantation: causes and treatment.
Q45214561Determinants of health utility in lung and heart-lung transplant recipients
Q44543685Effect of switching from cyclosporine to tacrolimus on exhaled nitric oxide and pulmonary function in patients with chronic rejection after lung transplantation
Q51623828Feasibility of sputum induction in lung transplant recipients.
Q47819035Functional status and quality of life in patients surviving 10 years after lung transplantation
Q35153996Health-related quality of life in patients who develop bronchiolitis obliterans syndrome following allo-SCT.
Q24817037Incomplete quality of life data in lung transplant research: comparing cross sectional, repeated measures ANOVA, and multi-level analysis
Q51027505Long-term quality of life in patients surviving at least 55 months after lung transplantation.
Q34535317Longitudinal profile of bronchoalveolar lavage cell characteristics in patients with a good outcome after lung transplantation
Q83778591Lung and heart-lung transplantation
Q46903642Lung transplant recipients holding companion animals: impact on physical health and quality of life
Q37056113Lung transplantation in advanced COPD: is it worth it?
Q35293950Lung transplantation. Bronchiolitis obliterans syndrome
Q46773243Negative effects of pretransplant body mass index on physical health-related quality of life after lung transplant
Q40049050Patient-reported health outcomes in long-term lung transplant survivors: a prospective cohort study
Q36429869Patient-reported outcome 2 years after lung transplantation: does the underlying diagnosis matter?
Q37706330Practical guidelines: lung transplantation in patients with cystic fibrosis
Q36385117Psychiatric Predictors of Long-term Transplant-Related Outcomes in Lung Transplant Recipients
Q37978742Psychiatric disorders as risk factors for adverse medical outcomes after solid organ transplantation
Q26991812Psychosocial issues facing lung transplant candidates, recipients and family caregivers
Q51946077Psychosocial vulnerability, physical symptoms and physical impairment after lung and heart–lung transplantation
Q35894922Quality of life after lung transplantation
Q51901624Quality of life and bronchiolitis obliterans syndrome in patients after lung transplantation.
Q51728837Quality of life before and after lung transplantation in patients with emphysema versus other indications.
Q36777920Quality of life following organ transplantation
Q38118961Quality of life in lung transplantation
Q53492448Quality of life issues in transplantation: thoracic organ transplantation.
Q35649145Reliability and validity of a Dutch version of the Leicester Cough Questionnaire
Q50962612Stress, psychological distress, and coping in patients on the waiting list for lung transplantation: an exploratory study.
Q34172126Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients
Q37061393Technology and outcomes assessment in lung transplantation
Q53336827The effect of bronchiolitis obliterans syndrome on health related quality of life.
Q40530295The societal impact of single versus bilateral lung transplantation for chronic obstructive pulmonary disease
Q36410255To transplant or not? The importance of psychosocial and behavioural factors before lung transplantation
Q59132479Transplant options for end stage chronic obstructive pulmonary disease in the context of multidisciplinary treatments
Q81161254[Lung transplantation in patients with pulmonary fibrosis]

Search more.